Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
about
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease.Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research.Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts
P2860
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@ast
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@en
type
label
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@ast
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@en
prefLabel
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@ast
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@en
P2860
P1476
Treatment of moderate to severe Alzheimer's disease: rationale and trial design.
@en
P2093
Nathan Herrmann
P2860
P304
P356
10.1017/S0317167100005667
P478
34 Suppl 1
P577
2007-03-01T00:00:00Z